MERCK & CO Aktie

 

Based on the average brokerage recommendation (ABR), Merck (MRK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?...

In the closing of the recent trading day, Merck (MRK) stood at $120.76, denoting a +1.4% move from the preceding trading day....

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store....

KENILWORTH (NJ) (dpa-AFX) - Merck Animal Health, a division of Merck & Co. (MRK), on Thursday announced a definitive agreement to acquire TARGAN, a privately held developer of biodevice solutions ......

TARGAN's innovative high-speed biodevice technology, including its gender identification product WingScan™, delivers enhanced poultry performanceRAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that it has signed a definitive agreement to acquire TARGAN, a privately held innovator in developing and commercializing biodevice solutions to improve performance outcomes for the poultry industry, for an undisclosed purchase price. Merck Animal Health has invested in TARGAN since 2017 and has been one of the company's largest shareholders. The proposed acquisition is expected to be completed in the third quarter of 2026, subject to approvals from applicable regulatory authorities and other customary closing conditions. “The acquisition of TARGAN's best-in-class biodevice technology for use in commercial hatcheries complements and accelerates our growing biop...

MRK has reclaimed its 50-day SMA while holding above its 200-day trendline, backed by Keytruda growth, pipeline advances and recent deals....

Gilead Sciences Inc. and Merck & Co. said an experimental long acting pill combining two HIV medicines had met its primary efficacy goal in final-stage trials....

Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?...

Merck & Co. says it will settle a spate of lawsuits that blame the drugmaker's blockbuster Gardasil cancer vaccine for causing autoimmune ailments that affect young women's hearts and reproductive systems for an amount that is “not material” to the pharma firm....

Pfizer (NYSE:PFE) and Merck (NYSE:MRK) both just closed earnings chapters that frame the 2026 dividend debate clearly. Pfizer wrapped fiscal 2025 with a $0.66 adjusted EPS Q4 beat. Merck followed with a Q1 2026 report dominated by a $9 billion Cidara acquisition charge. Two very different income stories for yield hunters. One Pays You to ... Pfizer vs Merck: Chasing High Yield vs Higher Returns...

MRK wins FDA Breakthrough Therapy designation for calderasib plus Keytruda for certain newly diagnosed metastatic KRAS G12C-mutant NSCLC patients....

Merck bets on newer drugs, pipeline candidates and M&A deals to offset looming Keytruda patent expiry and drive long-term growth....

Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.85 per share of the company's common stock for the third quarter of 2026. Payment will be made on July 8, 2026, to shareholders of record at the close of business on June 15, 2026. About Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every d...

Janux Therapeutics advances multiple oncology and immune therapy programs with key clinical updates, new studies and expanded partnerships with BMY and MRK....

Mit einem Kursplus von 5,64 Prozent auf 122,41 Dollar hat die Aktie des Pharma-Konzerns Merck & Co am Freitag in den USA für Aufsehen gesorgt. Damit kletterte die Marktkapitalisierung des US-amerikanischen Unternehmens wieder über die Marke von 300 Milliarden Dollar....

FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Dienstag, den 26. Mai^TERMINE UNTERNEHMEN08:00 GBR: Kingfisher, Q1-Umsatz10:00 DEU: Sparkassenverband Rheinland-Pfalz, Bilanz-Pk, Mainz15:00 USA: Merck & Co, HauptversammlungTERMINE ......

Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag....

Merck jumps after CHMP backs Keytruda plus Padcev for certain bladder cancer patients, a combo with the potential to expand treatment options....

FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Dienstag, den 26. Mai^TERMINE UNTERNEHMEN08:00 GBR: Kingfisher, Q1-Umsatz10:00 DEU: Sparkassenverband Rheinland-Pfalz, Bilanz-Pk, Mainz15:00 USA: Merck & Co, HauptversammlungTERMINE ......